XML 19 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements Of Cash Flows - USD ($)
 4 Months Ended 5 Months Ended 9 Months Ended
Apr. 30, 2021
Sep. 30, 2021
Sep. 30, 2022
OPERATING ACTIVITIES      
Net income (loss) $ (4,463,800,000) $ (56,900,000) $ 150,700,000
Adjustments to reconcile net income (loss) to net cash used in operating activities:      
Gain on asset disposals (6,000,000.0) (200,000) (137,700,000)
Depreciation expense 159,600,000 41,000,000.0 67,400,000
Accretion of discount on notes receivable 0 (12,900,000) (37,800,000)
Loss on impairment 756,500,000 0 34,500,000
Equity in earnings of ARO (3,100,000) (7,400,000) (15,900,000)
Net periodic pension and retiree medical income (5,400,000) (6,100,000) (12,100,000)
Share-based compensation expense 4,800,000 1,600,000 11,500,000
Amortization, net (4,800,000) 2,800,000 (7,000,000.0)
Deferred income tax expense (benefit) (18,200,000) 1,200,000 7,100,000
Amortization of debt issuance cost 0 300,000 700,000
Non-cash reorganization items, net 3,487,300,000 0 0
Other 7,300,000 0 800,000
Changes in operating assets and liabilities 68,500,000 19,300,000 (85,900,000)
Contributions to pension plans and other post-retirement benefits 22,500,000 1,700,000 3,300,000
Net cash used in operating activities (39,800,000) (19,000,000.0) (27,000,000.0)
INVESTING ACTIVITIES      
Purchases of short-term investments 0 0 (220,000,000.0)
Additions to property and equipment (8,700,000) (23,700,000) (153,100,000)
Net proceeds from disposition of assets 30,100,000 1,500,000 146,800,000
Repayments of note receivable from ARO 0 0 40,000,000.0
Net cash provided by (used in) investing activities 21,400,000 (22,200,000) (186,300,000)
FINANCING ACTIVITIES      
Consent solicitation fees 0 0 (3,900,000)
Payments for tax withholdings for share-based awards 0 0 2,500,000
Issuance of first lien notes 520,000,000.0 0 0
Payments to Predecessor creditors 129,900,000 0 0
Other (1,400,000) 0 0
Net cash provided by (used in) financing activities 388,700,000 0 (6,400,000)
Effect of exchange rate changes on cash and cash equivalents and restricted cash (100,000) (100,000) (700,000)
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH 370,200,000 (41,300,000) (220,400,000)
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD 325,800,000 696,000,000.0 644,600,000
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD $ 696,000,000.0 $ 654,700,000 $ 424,200,000